Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

(NASDAQ:SONN),(NASDAQ:PURR), NEW YORK and PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) — Hyperliquid Strategies Inc (“HSI” or the “Company”) and Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) (“Sonnet”) today announced the completion of the closing of the previously announced business combination among HSI, Sonnet and Rorschach I LLC (“Rorschach”), a newly-formed entity formed by an entity […]

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:OLMA), SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to two new employees to purchase an aggregate of 65,000

Publication relating to transparency notifications

(Brussels:NYXH),(NasdaqGM:NYXH), REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Robert

Evertz Technologies Limited to Announce Second Quarter 2026 Results on December 10, 2025

Burlington, Ontario–(Newsfile Corp. – December 2, 2025) – Evertz Technologies Limited (TSX: ET) will release its second quarter 2026 financial results on December 10, 2025 at approximately 4:00 p.m. (EDT). The Company will hold a conference call with financial analysts to discuss the results on December 10, 2025 at 5:00 p.m. (EDT). Media and other

Brunswick Exploration Announces Non-Brokered Private Placement of $1.5M

Brunswick Exploration Announces Non-Brokered Private Placement of $1.5M GlobeNewswire December 02, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Dec. 02, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Corporation“) is pleased to announce a non-brokered private placement (the “Offering“)

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Under the Ticker “PURR” GlobeNewswire December 02, 2025 NEW YORK and PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) — Hyperliquid Strategies Inc (“HSI” or the “Company”) and Sonnet

Publication relating to transparency notifications

Publication relating to transparency notifications GlobeNewswire December 02, 2025 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it

AMG to Present at the Goldman Sachs Financial Services Conference

AMG to Present at the Goldman Sachs Financial Services Conference GlobeNewswire December 02, 2025 WEST PALM BEACH, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — AMG, a strategic partner to leading independent investment management firms globally, announced today that Jay C. Horgen, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Financial Services Conference

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 02, 2025 SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company

Public advisory – Imported pistachios from Iran: What you need to know

Summary Product: Imported pistachios from Iran and products made with pistachios from IranIssue: Food – Microbial contamination – SalmonellaWhat to do:Check CFIA's Food Safety Investigation pageto see if you have affected products. Do not eat recalled pistachios or pistachio-containing products or use them in cooking or baking. Throw out or return recalled products to the

Scroll to Top